The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells

Nature Immunology

Volumn 18, Issue 2, 2017, Pages 184-195

  Beyaz, Semir ^a,b,g   Kim, Ji Hyung ^a,g   Pinello, Luca ^c,g   Xifaras, Michael E ^d,j   Hu, Yu ^a   Huang, Jialiang ^c,i   Kerenyi, Marc A ^a,b,e   Das, Partha P ^a,b   Barnitz, R Anthony ^a,f   Herault, Aurelie ^f   Dogum, Rizkullah ^d   Haining, W Nicholas ^a,f   Yilmaz, Ömer H ^d   Passegue, Emmanuelle ^f   Yuan, Guo Cheng ^c   Orkin, Stuart H ^a,b,h   Winau, Florian ^a,h  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEMETHYLASE; HISTONE DEMETHYLASE UTX; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR PLZF; UNCLASSIFIED DRUG; JUNB PROTEIN, MOUSE; KRUPPEL LIKE FACTOR; UTX PROTEIN, MOUSE; ZBTB16 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; ENZYME ACTIVITY; ENZYME BINDING; EPIGENETICS; GENE EXPRESSION; GENE INACTIVATION; GENE TARGETING; GENETIC REGULATION; INNATE IMMUNITY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONE DEMETHYLASES; IMMUNITY, INNATE; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS;

EID: 85006355478     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3644     Document Type: Article

References (60)

1. Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
2. Rossjohn, J., Pellicci, D.G., Patel, O., Gapin, L. & Godfrey, D.I. Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12, 845-857 (2012).
3. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
4. Cui, J. et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626 (1997).
5. Bendelac, A. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182, 2091-2096 (1995).
6. Lazarevic, V. et al. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 10, 306-313 (2009).
7. Kovalovsky, D. et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9, 1055-1064 (2008).
8. Savage, A.K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391-403 (2008).
9. Seiler, M.P. et al. Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT cell lineage differentiation in response to TCR signaling. Nat. Immunol. 13, 264-271 (2012).
10. Matsuda, J.L. et al. Homeostasis of Vα14i NKT cells. Nat. Immunol. 3, 966-974 (2002).
11. Townsend, M.J. et al. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20, 477-494 (2004).
12. Engel, I. & Kronenberg, M. Transcriptional control of the development and function of Vα14i NKT cells. Curr. Top. Microbiol. Immunol. 381, 51-81 (2014).
13. Cohen, N.R. et al. Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat. Immunol. 14, 90-99 (2013).
14. Whyte, W.A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307-319 (2013).
15. Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934-947 (2013).
16. Kouzarides, T. Chromatin modifications and their function. Cell 128, 693-705 (2007).
17. Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283 (2011).
18. Creyghton, M.P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 107, 21931-21936 (2010).
19. Simon, J.A. & Kingston, R.E. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 10, 697-708 (2009).
20. Bernstein, B.E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326 (2006).
21. Agger, K. et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449, 731-734 (2007).
22. Lan, F. et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449, 689-694 (2007).
23. Lee, M.G. et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318, 447-450 (2007).
24. De Santa, F. et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130, 1083-1094 (2007).
25. Heintzman, N.D. et al. Histone modifications at human enhancers reflect global cell-Type-specific gene expression. Nature 459, 108-112 (2009).
26. Welstead, G.G. et al. X-linked H3K27me3 demethylase Utx is required for embryonic development in a sex-specific manner. Proc. Natl. Acad. Sci. USA 109, 13004-13009 (2012).
27. Mansour, A.A. et al. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature 488, 409-413 (2012).
28. Li, Q. et al. Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation. Nat. Commun. 5, 5780 (2014).
29. Lee, S., Lee, J.W. & Lee, S.K. UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac developmental program. Dev. Cell 22, 25-37 (2012).
30. Thieme, S. et al. The histone demethylase UTX regulates stem cell migration and hematopoiesis. Blood 121, 2462-2473 (2013).
31. Ntziachristos, P. et al. Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. Nature 514, 513-517 (2014).
32. van Haaften, G. et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 41, 521-523 (2009).
33. Cook, K.D. et al. T follicular helper cell-dependent clearance of a persistent virus infection requires T cell expression of the histone demethylase UTX. Immunity 43, 703-714 (2015).
34. Manna, S. et al. Histone H3 lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation. Nat. Commun. 6, 8152 (2015).
35. Dobenecker, M.W. et al. Coupling of T cell receptor specificity to natural killer T cell development by bivalent histone H3 methylation. J. Exp. Med. 212, 297-306 (2015).
36. Benlagha, K., Wei, D.G., Veiga, J., Teyton, L. & Bendelac, A. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202, 485-492 (2005).
37. Lee, Y.J., Holzapfel, K.L., Zhu, J., Jameson, S.C. & Hogquist, K.A. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14, 1146-1154 (2013).
38. Gapin, L., Matsuda, J.L., Surh, C.D. & Kronenberg, M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2, 971-978 (2001).
39. Mao, A.P. et al. Multiple layers of transcriptional regulation by PLZF in NKT cell-cell development. Proc. Natl. Acad. Sci. USA 113, 7602-7607 (2016).
40. Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y. & Greenleaf, W.J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213-1218 (2013).
41. Pinello, L., Xu, J., Orkin, S.H. & Yuan, G.C. Analysis of chromatin-state plasticity identifies cell-Type-specific regulators of H3K27me3 patterns. Proc. Natl. Acad. Sci. USA 111, E344-E353 (2014).
42. Kanda, M. et al. Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells. Proc. Natl. Acad. Sci. USA 113, E3394-E3402 (2016).
43. Engel, I. et al. Innate-like functions of natural killer T cell subsets result from highly divergent gene programs. Nat. Immunol. 17, 728-739 (2016).
44. Williams, K.L. et al. BATF transgenic mice reveal a role for activator protein-1 in NKT cell development. J. Immunol. 170, 2417-2426 (2003).
45. Jordan-Williams, K.L., Poston, S. & Taparowsky, E.J. BATF regulates the development and function of IL-17 producing iNKT cells. BMC Immunol. 14, 16 (2013).
46. Lawson, V.J., Maurice, D., Silk, J.D., Cerundolo, V. & Weston, K. Aberrant selection and function of invariant NKT cells in the absence of AP-1 transcription factor Fra-2. J. Immunol. 183, 2575-2584 (2009).
47. Thomsen, M.K. et al. JUNB/AP-1 controls IFN-γ during inflammatory liver disease. J. Clin. Invest. 123, 5258-5268 (2013).
48. Miller, S.A., Mohn, S.E. & Weinmann, A.S. Jmjd3 and UTX play a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression. Mol. Cell 40, 594-605 (2010).
49. Pereira, R.M. et al. Jarid2 is induced by TCR signalling and controls iNKT cell maturation. Nat. Commun. 5, 4540 (2014).
50. Vahedi, G. et al. Super-enhancers delineate disease-Associated regulatory nodes in T cells. Nature 520, 558-562 (2015).
51. Passegué, E., Wagner, E.F. & Weissman, I.L. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 119, 431-443 (2004).
52. Irizarry, R.A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264 (2003).
53. Johnson, W.E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 (2007).
54. Smyth, G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3 (2004).
55. McLean, C.Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495-501 (2010).
56. Kurachi, M. et al. The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells. Nat. Immunol. 15, 373-383 (2014).
57. Langmead, B. & Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359 (2012).
58. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
59. Rousseeuw, P.J. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 20, 53-65 (1987).
60. Mathelier, A. et al. JASPAR 2014: An extensively expanded and updated open-Access database of transcription factor binding profiles. Nucleic Acids Res. 42, D142-D147 (2014).